Nuclear Medicine Market Size, Share, Growth, and Industry Analysis, By Type (Diagnostic Nuclear Medicine,Therapeutic Nuclear Medicine), By Application (Oncology,Thyroid,Cardiology,Others), Regional Insights and Forecast to 2035

Detailed TOC of Global Nuclear Medicine Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Medicine Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Nuclear Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
3.5 Global Key Players of Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Nuclear Medicine, Product and Application
3.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Medicine Market Size (2020-2031)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Medicine Market Size by Country (2020-2025)
6.4 North America Nuclear Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2020-2031)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.4 Europe Nuclear Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2020-2031)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Medicine Market Size by Country (2020-2025)
9.4 Latin America Nuclear Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Nuclear Medicine Introduction
11.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nuclear Medicine Introduction
11.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Details
11.3.2 Jubilant Pharma Business Overview
11.3.3 Jubilant Pharma Nuclear Medicine Introduction
11.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.3.5 Jubilant Pharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Nuclear Medicine Introduction
11.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Nuclear Medicine Introduction
11.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 SIEMENS
11.6.1 SIEMENS Company Details
11.6.2 SIEMENS Business Overview
11.6.3 SIEMENS Nuclear Medicine Introduction
11.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
11.6.5 SIEMENS Recent Development
11.7 Lantheus
11.7.1 Lantheus Company Details
11.7.2 Lantheus Business Overview
11.7.3 Lantheus Nuclear Medicine Introduction
11.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
11.7.5 Lantheus Recent Development
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Details
11.8.2 Bracco Imaging Business Overview
11.8.3 Bracco Imaging Nuclear Medicine Introduction
11.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.8.5 Bracco Imaging Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Nuclear Medicine Introduction
11.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Nuclear Medicine Introduction
11.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Nuclear Medicine Introduction
11.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.11.5 Aurobindo Pharma Recent Development
11.12 Mundipharma
11.12.1 Mundipharma Company Details
11.12.2 Mundipharma Business Overview
11.12.3 Mundipharma Nuclear Medicine Introduction
11.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
11.12.5 Mundipharma Recent Development
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Details
11.13.2 China Isotope & Radiation Business Overview
11.13.3 China Isotope & Radiation Nuclear Medicine Introduction
11.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
11.13.5 China Isotope & Radiation Recent Development
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Details
11.14.2 Yantai Dongcheng Business Overview
11.14.3 Yantai Dongcheng Nuclear Medicine Introduction
11.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
11.14.5 Yantai Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer